Archive


Category: Antiviral drugs

  • Timing of Remdesivir for COVID-19

    Date:  October 19, 2020 Issue #:  1609 Summary:  Remdesivir (Veklury – Gilead), an investigational antiviral drug administered by IV infusion, is now available through an FDA Emergency Use Authorization (EUA) for treatment of COVID-19 in all hospitalized patients. An earlier EUA limited use of the drug to patients hospitalized with severe disease.